Skip to main content
PMC home page
Gut logoLink to Gut
. 1994 Aug;35(8):1018–1021. doi: 10.1136/gut.35.8.1018

Diagnosis of invasive amoebiasis--time to end the morphology era.

J I Ravdin 1
PMCID: PMC1375045  PMID: 7926897

Full text

PDF
1018

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Abd-Alla M. D., Jackson T. F., Gathiram V., el-Hawey A. M., Ravdin J. I. Differentiation of pathogenic Entamoeba histolytica infections from nonpathogenic infections by detection of galactose-inhibitable adherence protein antigen in sera and feces. J Clin Microbiol. 1993 Nov;31(11):2845–2850. doi: 10.1128/jcm.31.11.2845-2850.1993. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Abd-Alla M. D., el-Hawey A. M., Ravdin J. I. Use of an enzyme-linked immunosorbent assay to detect anti-adherence protein antibodies in sera of patients with invasive amebiasis in Cairo, Egypt. Am J Trop Med Hyg. 1992 Dec;47(6):800–804. doi: 10.4269/ajtmh.1992.47.800. [DOI] [PubMed] [Google Scholar]
  3. Acuna-Soto R., Samuelson J., De Girolami P., Zarate L., Millan-Velasco F., Schoolnick G., Wirth D. Application of the polymerase chain reaction to the epidemiology of pathogenic and nonpathogenic Entamoeba histolytica. Am J Trop Med Hyg. 1993 Jan;48(1):58–70. doi: 10.4269/ajtmh.1993.48.58. [DOI] [PubMed] [Google Scholar]
  4. Clark C. G., Diamond L. S. Ribosomal RNA genes of 'pathogenic' and 'nonpathogenic' Entamoeba histolytica are distinct. Mol Biochem Parasitol. 1991 Dec;49(2):297–302. doi: 10.1016/0166-6851(91)90073-f. [DOI] [PubMed] [Google Scholar]
  5. Gathiram V., Jackson T. F. Frequency distribution of Entamoeba histolytica zymodemes in a rural South African population. Lancet. 1985 Mar 30;1(8431):719–721. doi: 10.1016/s0140-6736(85)91263-2. [DOI] [PubMed] [Google Scholar]
  6. Gonzalez-Ruiz A., Haque R., Rehman T., Aguirre A., Jaramillo C., Castañon G., Hall A., Guhl F., Ruiz-Palacios G., Warhurst D. C. A monoclonal antibody for distinction of invasive and noninvasive clinical isolates of Entamoeba histolytica. J Clin Microbiol. 1992 Nov;30(11):2807–2813. doi: 10.1128/jcm.30.11.2807-2813.1992. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Grundy M. S. Preliminary observations using a multi-layer ELISA method for the detection of Entamoeba histolytica trophozoite antigens in stool samples. Trans R Soc Trop Med Hyg. 1982;76(3):396–400. doi: 10.1016/0035-9203(82)90199-7. [DOI] [PubMed] [Google Scholar]
  8. Haque R., Kress K., Wood S., Jackson T. F., Lyerly D., Wilkins T., Petri W. A., Jr Diagnosis of pathogenic Entamoeba histolytica infection using a stool ELISA based on monoclonal antibodies to the galactose-specific adhesin. J Infect Dis. 1993 Jan;167(1):247–249. doi: 10.1093/infdis/167.1.247. [DOI] [PubMed] [Google Scholar]
  9. Irusen E. M., Jackson T. F., Simjee A. E. Asymptomatic intestinal colonization by pathogenic Entamoeba histolytica in amebic liver abscess: prevalence, response to therapy, and pathogenic potential. Clin Infect Dis. 1992 Apr;14(4):889–893. doi: 10.1093/clinids/14.4.889. [DOI] [PubMed] [Google Scholar]
  10. Katzenstein D., Rickerson V., Braude A. New concepts of amebic liver abscess derived from hepatic imaging, serodiagnosis, and hepatic enzymes in 67 consecutive cases in San Diego. Medicine (Baltimore) 1982 Jul;61(4):237–246. doi: 10.1097/00005792-198207000-00003. [DOI] [PubMed] [Google Scholar]
  11. Krogstad D. J., Spencer H. C., Jr, Healy G. R., Gleason N. N., Sexton D. J., Herron C. A. Amebiasis: epidemiologic studies in the United States, 1971-1974. Ann Intern Med. 1978 Jan;88(1):89–97. doi: 10.7326/0003-4819-88-1-89. [DOI] [PubMed] [Google Scholar]
  12. Mann B. J., Chung C. Y., Dodson J. M., Ashley L. S., Braga L. L., Snodgrass T. L. Neutralizing monoclonal antibody epitopes of the Entamoeba histolytica galactose adhesin map to the cysteine-rich extracellular domain of the 170-kilodalton subunit. Infect Immun. 1993 May;61(5):1772–1778. doi: 10.1128/iai.61.5.1772-1778.1993. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Merino E., Glender W., del Muro R., Ortiz-Ortiz L. Evaluation of the ELISA test for detection of Entamoeba histolytica in feces. J Clin Lab Anal. 1990;4(1):39–42. doi: 10.1002/jcla.1860040108. [DOI] [PubMed] [Google Scholar]
  14. Petri W. A., Jr, Chapman M. D., Snodgrass T., Mann B. J., Broman J., Ravdin J. I. Subunit structure of the galactose and N-acetyl-D-galactosamine-inhibitable adherence lectin of Entamoeba histolytica. J Biol Chem. 1989 Feb 15;264(5):3007–3012. [PubMed] [Google Scholar]
  15. Petri W. A., Jr, Jackson T. F., Gathiram V., Kress K., Saffer L. D., Snodgrass T. L., Chapman M. D., Keren Z., Mirelman D. Pathogenic and nonpathogenic strains of Entamoeba histolytica can be differentiated by monoclonal antibodies to the galactose-specific adherence lectin. Infect Immun. 1990 Jun;58(6):1802–1806. doi: 10.1128/iai.58.6.1802-1806.1990. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. Petri W. A., Jr, Smith R. D., Schlesinger P. H., Murphy C. F., Ravdin J. I. Isolation of the galactose-binding lectin that mediates the in vitro adherence of Entamoeba histolytica. J Clin Invest. 1987 Nov;80(5):1238–1244. doi: 10.1172/JCI113198. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. Ravdin J. I., Jackson T. F., Petri W. A., Jr, Murphy C. F., Ungar B. L., Gathiram V., Skilogiannis J., Simjee A. E. Association of serum antibodies to adherence lectin with invasive amebiasis and asymptomatic infection with pathogenic Entamoeba histolytica. J Infect Dis. 1990 Sep;162(3):768–772. doi: 10.1093/infdis/162.3.768. [DOI] [PubMed] [Google Scholar]
  18. Sargeaunt P. G., Williams J. E., Grene J. D. The differentiation of invasive and non-invasive Entamoeba histolytica by isoenzyme electrophoresis. Trans R Soc Trop Med Hyg. 1978;72(5):519–521. doi: 10.1016/0035-9203(78)90174-8. [DOI] [PubMed] [Google Scholar]
  19. Smith P. D., Lane H. C., Gill V. J., Manischewitz J. F., Quinnan G. V., Fauci A. S., Masur H. Intestinal infections in patients with the acquired immunodeficiency syndrome (AIDS). Etiology and response to therapy. Ann Intern Med. 1988 Mar;108(3):328–333. doi: 10.7326/0003-4819-108-3-328. [DOI] [PubMed] [Google Scholar]
  20. Tannich E., Ebert F., Horstmann R. D. Primary structure of the 170-kDa surface lectin of pathogenic Entamoeba histolytica. Proc Natl Acad Sci U S A. 1991 Mar 1;88(5):1849–1853. doi: 10.1073/pnas.88.5.1849. [DOI] [PMC free article] [PubMed] [Google Scholar]
  21. Tannich E., Horstmann R. D., Knobloch J., Arnold H. H. Genomic DNA differences between pathogenic and nonpathogenic Entamoeba histolytica. Proc Natl Acad Sci U S A. 1989 Jul;86(13):5118–5122. doi: 10.1073/pnas.86.13.5118. [DOI] [PMC free article] [PubMed] [Google Scholar]
  22. el-Hennawy M., Abd-Rabbo H. Hazards of cortisone therapy in hepatic amoebiasis. J Trop Med Hyg. 1978 Apr;81(4):71–73. [PubMed] [Google Scholar]

Articles from Gut are provided here courtesy of BMJ Publishing Group

RESOURCES